Rapidly progressive hepatic alveolar echinococcosis in an ABO-incompatible renal transplant recipient

Transplant Infectious Disease

Volumn 13, Issue 3, 2011, Pages 278-284

  Geyer, Marcel ^a   Wilpert, J ^b   Wiech, T ^a,c   Theilacker, C ^a   Stubanus, M ^a   Kramer Zucker, A ^a   Fischer, K G ^a   Drognitz, O ^a   Frydrychowicz, A ^a   Kern, W ^a   Walz, G ^a   Pisarski, P ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HBH Kliniken Singen   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ABO incompatible; Echinococcosis; Echinococcus multilocularis; Hydatid; Renal transplantation; Rituximab

Indexed keywords

ALBENDAZOLE; BASILIXIMAB; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS;

ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; ECHINOCOCCUS MULTILOCULARIS; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULOPATHY; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVER HYDATID CYST; LIVER RESECTION; LIVER TUMOR; LOW DRUG DOSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SINGLE DRUG DOSE; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ABO BLOOD-GROUP SYSTEM; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; BLOOD GROUP INCOMPATIBILITY; DISEASE PROGRESSION; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS MULTILOCULARIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; TIME FACTORS;

EID: 79957987594     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00583.x     Document Type: Article

References (26)

1. Schweiger A. Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis 2007; 13: 878-882.
2. McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet 2003; 362: 1295-1304.
3. Craig P. Echinococcus multilocularis. Curr Opin Infect Dis 2003; 16: 437-444.
4. Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107-135.
5. Bresson-Hadni S, Vuitton DA, Barthlomot B, et al. A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol 2000; 12: 327-336.
6. Sailer M, Soelder B, Allerberger F, Zaknun D, Feichtinger H, Gottstein B. Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr 1997; 130: 320-323.
7. Bresson-Hadni S, Koch S, Beurton I, et al. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients. Hepatology 1999; 30: 857-864.
8. Palmiero G, Ciampi R, Gallo R, Federico S, Sabbatini M. Liver echinococcosis in a renal transplant patient: a particularly intriguing case report. J Nephrol 2008; 21: 442-445.
9. Cavdar C, Celik A, Saglam F, et al. Isolated hydatid disease of the native kidney in a renal transplant recipient. Nephrol Dial Transplant 2007; 22: 656-657.
10. Sqalli TH, Buchler M, Najjar AA, et al. Hydatid disease in a renal allograft recipient. Saudi J Kidney Dis Transpl 2009; 20: 1057-1060.
11. Tydén G, Donauer J, Wadström J, Kumlien G, Wilpert J, Nilsson T. Implementation of a protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153-1155.
12. Moro P, Schantz P. Echinococcosis: a review. Intern J Infect Dis 2009; 13: 125-133.
13. Pedrosa I, Saiz A, Arrazola J, Ferreiros J, Pedrosa CS. Hydatid disease: radiologic and pathologic features and complications. RadioGraphics 2000; 20: 795-817.
14. Lewall DB. Hydatid disease: biology, pathology, imaging and classification. Clin Radiol 1998; 53: 863-874.
15. Zhang W, McManus DP. Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol 2006; 47: 24-41.
16. Genberg H, Kumlien G, Wennberg L, Berg U, Tydén G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008; 85: 1745-1754.
17. Wilpert J, Fischer KG, Pisarski P, et al. Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis. Nephrol Dial Transplant 2010 [Epub ahead of print].
18. Cooper N, Arnold DM. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. Br J Haematol 2010; 149: 3-13.
19. Jordan SC, Glotz D. Is rituximab safe to use in kidney transplant patients? Am J Transplant 2010; 10: 8-9.
20. Zhang W, Ross AG, McManus DP. Mechanisms of immunity in hydatid disease: implications for vaccine development. J Immunol 2008; 181: 6679-6685.
21. German Registry of Infectious Diseases. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2009, pp. 65-67, Robert Koch Institut. Available at
22. Dyachenko V, Pantchev N, Gawlowska S, Vrhovec MG, Bauer C. Echinococcus multilocularis infections in domestic dogs and cats from Germany and other European countries. Vet Parasitol 2008; 157: 244-253.
23. United States Centers for Disease Control and Prevention - Healthy Pets, Healthy People. Available at
24. Covic A, Mititiuc I, Caruntu L, Goldsmith DJ. Reversible nephrotic syndrome due to mesangiocapillary glomerulonephritis secondary to hepatic hydatid disease. Nephrol Dial Transplant 1996; 11: 2074-2076.
25. Edelweiss MI, Daudt HM, Goldstein HF, Garcia C. Hepatic hydatosis with glomerular involvement: report of a case. AMB 1992; 38: 31-32.
26. Mortele K, Ros P. Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 2001; 21: 895-910.